Suchergebnisse - "Prens, Errol P."

PubPharm (192)

1

Bacterial Microbiota Composition in Hidradenitis Suppurativa Differs per Skin Layer

enthalten in: The Journal of investigative dermatology | 2024

von Pardo, L. | Wang, C. | Ardon, C. | +3

2

Viewpoint on the evaluation of severity and treatment effects in mild hidradenitis suppurativa : the cumulative IHS4 (IHS4-C)

enthalten in: Dermatology (Basel, Switzerland) | 2023

von van der Zee, H. | van Huijstee, J. | van Straalen, K. | +4

3

International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging : A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2023

von Zouboulis, C. | Prens, E. | Sayed, C. | +13

4

Needle-free electronically controlled jet injection with corticosteroids in recalcitrant keloid scars : a retrospective study and patient survey

enthalten in: Lasers in medical science | 2023

von Bik, L. | Elmzoon, I. | Wolkerstorfer, A. | +2

5

Needle-free electronically controlled jet injection with corticosteroids in recalcitrant keloid scars: a retrospective study and patient survey

enthalten in: Lasers in medical science | 2023

von Bik, L. | Elmzoon, I. | Wolkerstorfer, A. | +2

6

Adalimumab in conjunction with surgery compared with adalimumab monotherapy for hidradenitis suppurativa : A Randomized Controlled Trial in a real-world setting

enthalten in: Journal of the American Academy of Dermatology | 2023

von Aarts, P. | van Huijstee, J. | van der Zee, H. | +3

CommentIn: J Am Acad Dermatol. 2023 Oct;89(4):671. - PMID 37169295

7

A multimodal, comprehensive characterization of a cutaneous wound model in healthy volunteers

enthalten in: Experimental dermatology | 2023

von Ten Voorde, W. | Saghari, M. | Boltjes, J. | +11

8

Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa : A Phase 2, Randomized, Placebo-Controlled Trial

enthalten in: Dermatology and therapy | 2023

von Kimball, A. | Prens, E. | Passeron, T. | +8

9

Guselkumab for hidradenitis suppurativa : a phase II, open-label, mode-of-action study

enthalten in: The British journal of dermatology | 2023

von Dudink, K. | Bouwman, K. | Chen, Y. | +11

CommentIn: Br J Dermatol. 2023 Apr 20;188(5):588-589. - PMID 36722365

10

Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial

enthalten in: Dermatology and therapy | 2023

von Kimball, A. | Prens, E. | Passeron, T. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]